SCHEMBL1607

SCHEMBL1607

CC(N)C1(c2ccc(Cl)c(Cl)c2)CCC1

nearest known ligand 0.90

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 16/20 0.90
SLC6A3 Q01959 16/20 0.90
SLC6A2 P23975 9/20 0.90
KCNH2 Q12809 4/20 0.60
CYP2D6 P10635 1/20 0.59
TRPV3 Q8NET8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2374 0.98 SLC6A4 (0.88) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6
SCHEMBL3517380 0.95 SLC6A4 (1.00) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6
SCHEMBL3521364 0.95 SLC6A4 (1.00) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6
SCHEMBL16205160 0.95 SLC6A4 (1.00) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6
SCHEMBL10008912 0.83 SLC6A4 (0.92) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6
SCHEMBL872306 0.83 SLC6A4 (0.92) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6
SCHEMBL17999801 0.81 SLC6A3 (0.66) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6
SCHEMBL17999818 0.81 SLC6A3 (0.66) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6
SCHEMBL17999816 0.81 SLC6A3 (0.66) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6
SCHEMBL16298324 0.81 SLC6A4 (0.76) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4767790-A ANTIDEPRESSANTS THE BOOTS COMPANY PLC (GB) 1988-08-30 US claimed
US-4522828-A CYCLOBUTYLALKYLAMINE COMPOUNDS, ANTIDEPRESSANTS THE BOOTS COMPANY PLC (GB) 1985-06-11 US claimed
WO-2000073379-A1 PROCESS FOR PREPARING A STABILIZED POLYESTER SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2000-12-07 WO disclosed
US-6127424-A N-METHYL-1-(1-(4-CHLOROPHENYL)CYCLOBUTYL)-3-METHYLBUTYLAMINE OR A PHARMACEUTICALLY SUITABLE SALT AS AN EXAMPLE; BIOAVAILABILITY; SIDE EFFECT REDUCTION KNOLL AKTIENGESESLLSCHAFT (DE) 2000-10-03 US disclosed
EP-0828484-A1 USE OF ARYL SUBSTITUTED CYCLOBUTYL ALKYL AMINES FOR THE TREATMENT OF OBESITY Knoll AG (DE) 1998-03-18 EP disclosed
WO-1996038134-A1 USE OF ARYL SUBSTITUTED CYCLOBUTYL ALKYL AMINES FOR THE TREATMENT OF OBESITY KNOLL AG (DE) 1996-12-05 WO disclosed
US-4814352-A ANTIDEPRESSANT CYCLOBUTYL BENZYLAMINE THE BOOTS COMPANY PLC (GB) 1989-03-21 US disclosed
US-4806570-A ANTIDEPRESSANTS THE BOOTS COMPANY PLC (GB) 1989-02-21 US disclosed
US-4767790-A ANTIDEPRESSANTS THE BOOTS COMPANY PLC (GB) 1988-08-30 US disclosed
US-4746680-A ANTIDEPRESSANTS THE BOOTS COMPANY P.L.C. (GB) 1988-05-24 US disclosed
US-4629727-A ANTIDEPRESSANTS THE BOOTS COMPANY PLC (GB) 1986-12-16 US disclosed
EP-0111994-B1 (1-ARYLCYCLOBUTYL) ALKYLAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS THERAPEUTIC AGENTS The Boots Company PLC (GB) 1986-02-26 EP disclosed
US-4522828-A CYCLOBUTYLALKYLAMINE COMPOUNDS, ANTIDEPRESSANTS THE BOOTS COMPANY PLC (GB) 1985-06-11 US disclosed
EP-0111994-A1 (1-Arylcyclobutyl) alkylamine derivatives, their preparation and their use as therapeutic agents The Boots Company PLC (GB) 1984-06-27 EP disclosed